EARNINGS: Shortwave Life Sciences half-year loss widens
30th Jan 2026 22:01
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
| Price | 128.50p on 03-03-2026 at 19:40:05 |
|---|---|
| Change | -1.00p -0.77% |
| Buy | 130.00p |
| Sell | 127.00p |
| Last Trade: | Buy 1,678.00 at 129.28p |
| Day's Volume: | 52,218 |
| Last Close: | 128.50p |
| Open: | 129.50p |
| ISIN: | GB00B2PP3J36 |
| Day's Range | 127.50p - 129.50p |
| 52wk Range: | 102.50p - 135.00p |
| Market Capitalisation: | £120.90m |
| VWAP: | 127.60632p |
| Shares in Issue: | 94.09m |
Sector: Closed End Investments
Ct Global Inc (CMPI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,678 | 129.28p | Ordinary |
16:26:11 - 03-Mar-26 |
| Buy* | 1,173 | 127.769p | Ordinary |
16:00:39 - 03-Mar-26 |
| Buy* | 905 | 127.77p | Ordinary |
15:57:30 - 03-Mar-26 |
| Buy* | 3,917 | 127.78p | Ordinary |
15:31:33 - 03-Mar-26 |
| Unknown* | 24,660 | 127.372p | Ordinary |
12:08:47 - 03-Mar-26 |
| Unknown* | 6,191 | 128.50p | Ordinary |
12:08:26 - 03-Mar-26 |
| Buy* | 1,606 | 129.40p | Ordinary |
11:20:54 - 03-Mar-26 |
| Sell* | 675 | 127.109p | Ordinary |
09:05:57 - 03-Mar-26 |
| Sell* | 1,967 | 127.107p | Ordinary |
09:02:53 - 03-Mar-26 |
| Sell* | 3,934 | 127.106p | Ordinary |
08:56:10 - 03-Mar-26 |
Ct Global Inc (CMPI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Mar 2026 2:15 pm | RNS | Total Voting Rights |
| 2nd Mar 2026 12:39 pm | RNS | Net Asset Value(s) |
| 27th Feb 2026 1:23 pm | RNS | Net Asset Value(s) |
| 26th Feb 2026 12:32 pm | RNS | Net Asset Value(s) |
| 25th Feb 2026 12:50 pm | RNS | Net Asset Value(s) |
| 24th Feb 2026 12:28 pm | RNS | Net Asset Value(s) |
| 23rd Feb 2026 1:21 pm | RNS | Net Asset Value(s) |
| 20th Feb 2026 12:57 pm | RNS | Net Asset Value(s) |
| 19th Feb 2026 4:52 pm | RNS | Portfolio Update |
| 19th Feb 2026 12:43 pm | RNS | Net Asset Value(s) |